Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
02/2003
02/11/2003US6518028 Methods for the early diagnosis of ovarian and prostate cancer
02/11/2003US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2
02/11/2003US6517830 In vivo gene delivery of nucleic acid sequences encoding the factor VIII protein to the liver endothelial sinusoidal cells; use in the gene therapy treatment of hemophilia A
02/11/2003US6517828 C-CAM as an angiogenesis inhibitor
02/11/2003CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
02/11/2003CA2142181C Androgen regulation with dna sequences of rat probasin gene
02/11/2003CA2141554C Morphogen-induced nerve regeneration and repair
02/08/2003CA2396616A1 Modified cdna for high expression levels of factor viii and its derivatives
02/06/2003WO2003010321A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy
02/06/2003WO2003010320A2 Recombinant vector derived from adeno-associated virus for gene therapy
02/06/2003WO2003010315A1 Abca7 splicing variant
02/06/2003WO2003010314A2 Gmg-2 polynucleotides and polypeptides and uses thereof
02/06/2003WO2003010310A1 Method of examining allergic disease
02/06/2003WO2003010306A1 Viral mutants that selectively replicate in targeted human cancer cells
02/06/2003WO2003010305A1 Immortilized stem cells
02/06/2003WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
02/06/2003WO2003010284A2 Antisense modulation of c-reactive protein expression
02/06/2003WO2003010205A1 Genes induced by hypoxia
02/06/2003WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003WO2003010192A2 An inducer of apoptosis
02/06/2003WO2003010184A2 A conserved xiap-interaction motif in caspase-9 and smac/diablo for mediating apoptosis
02/06/2003WO2003010180A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals
02/06/2003WO2003010139A2 Antisense modulation of hormone-sensitive lipase expression
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009866A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003WO2003009813A2 Methods of treating neuropilin-mediated diseases
02/06/2003WO2003009784A1 Ophthalmic drug delivery device
02/06/2003WO2002097134A3 Modified peptide nucleic acid
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002092772A3 Antisense modulation of ptp1b expression
02/06/2003WO2002090558A9 Novel expression vectors and uses thereof
02/06/2003WO2002085337B1 Micellar drug delivery systems for hydrophobic drugs
02/06/2003WO2002061110A3 Nucleic acid derivatives
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002055065A3 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
02/06/2003WO2002050263A3 Methods_for treating tissue damage by bone-marrow derived stem cells
02/06/2003WO2002044394A3 Targetet retoviral vectors for cancer immunotherapy
02/06/2003WO2002042317A3 Method of separating extra-chromosomal dna from other cellular components
02/06/2003WO2002038752A8 Use of a helminth for the in vivo delivery of a medicament
02/06/2003WO2002030470A9 Methods and compositions for nucleic acid delivery
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002016602A3 Compositions and methods for the diagnosis and treatment of tumor
02/06/2003WO2002016413A8 Cripto tumour polypeptide
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2001091801A3 Methods of transducing neural cells using lentivirus vectors
02/06/2003WO2001091725A9 Biologically useful polyphosphates
02/06/2003WO2001088199A3 Identification and modulationof of a t helper-1 and t helper-2 cells
02/06/2003WO2001082973A3 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
02/06/2003WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/06/2003WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
02/06/2003WO2001005437A3 Methods for treatment of hyperproliferative diseases using human mda-7
02/06/2003US20030028910 Animal model for use in the diagnosis and treatment dietetics
02/06/2003US20030028904 Genes involved in engulfment of dying cells and cell migration
02/06/2003US20030028010 Viral nucleotide sequene clone for use as tool in the treatment of viral diseases
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030028007 Vascular endothelial growth factor 2
02/06/2003US20030028006 Cytokine receptor common gamma chain like
02/06/2003US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027989 Nucleotide seq uences coding polypeptide for use in the diagnosis and treatment of cancer
02/06/2003US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders
02/06/2003US20030027784 Biologically tolerated low molecular weight polyethylenimines
02/06/2003US20030027783 Introducing into the cell an RNA comprising a double stranded structure having nucleotide sequence which is substantially identical to part of target gene and which is derived from an endogenous template; verifying inhibition of expression
02/06/2003US20030027782 Method for treating allergic lung disease
02/06/2003US20030027780 For transporting therapeutic, prophylactic and diagnostic agents across mucosal membranes such as gastrointestinal, buccal, nasal, rectal and vaginal
02/06/2003US20030027777 Methods for enhancing animal growth and cell proliferation by elimination of the cyclin-dependent kinase inhibitor function of p27Kip1
02/06/2003US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed
02/06/2003US20030027774 For diagnosis and therapy of tuberculosis
02/06/2003US20030027773 Protein-polycation conjugates
02/06/2003US20030027759 Method of using PON-1 to decrease atheroma formation
02/06/2003US20030027749 For use in therapy, and diagnostic assays
02/06/2003US20030027339 Micellar systems
02/06/2003US20030027337 Sequence-specific DNA recombination in eukaryotic cells
02/06/2003US20030027331 Homozygous stem cell for use in nervous system, endocrine, cancer, traumatic, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy
02/06/2003US20030027323 Novel human G-protein coupled receptor, HGPRBMY5, expressed highly in brain and ovarian tissues
02/06/2003US20030027322 Genration of herpesvirus amplicon particle for use in the treatment of cancer; obtain nucleotide sequences, incubate with expression vectors, ligate recover viral vector
02/06/2003US20030027314 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027284 Tumor necrosis factor-gamma
02/06/2003US20030027282 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027250 Methods and compositions for use in spliceosome mediated RNA trans-splicing
02/06/2003US20030027248 Human cDNAs and proteins and uses thereof
02/06/2003US20030027228 Detection of antiproliferative agents; obtain tumor cells, incubate with antiproliferative agent, monitor reduction in cancer activity
02/06/2003US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors
02/06/2003US20030027188 SLC7s as modifiers of the p53 pathway and methods of use
02/06/2003US20030027177 Human DNA mismatch repair proteins
02/06/2003US20030027170 Nucleotide sequence library for use as tool in genomic analysis
02/06/2003US20030027166 Nucleotide sequences coding polypeptides for use in the treatment of tumors
02/06/2003US20030027161 Human cDNAs and proteins and uses thereof
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins
02/06/2003US20030027151 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders
02/06/2003US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases
02/06/2003US20030026840 Immobilized into polyoxyethylene glycol
02/06/2003US20030026808 Anticholesterol agents; cardiovascular disorders
02/06/2003US20030026801 Methods for enhancing antibody-induced cell lysis and treating cancer
02/06/2003US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
02/06/2003US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 870